Moreover, the downregulation of vascular endothelial growth factor (VEGF), a mediator of angiogenesis, and Frizzled Class Receptor 4 (FZD4), may also contribute to further reducing invasiveness and cancer progression. Here, VEGFA is linked to cancer.